Branched-chain amino acids (BCAAs), particularly leucine, are potent activators of the mTORC1 signaling pathway, a key regulator of cell growth and metabolism. Chronic mTORC1 activation is linked to accelerated aging. By restricting dietary BCAAs, this strategy aims to dampen mTORC1 activity, mimicking some of the metabolic and longevity benefits of caloric or protein restriction, such as improved insulin sensitivity and glucose homeostasis.
Verdict
An experimental strategy with strong animal data, but unproven in humans.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
Low
EVIDENCE GRADE
C
MONTHLY COST
$0 - $50
Protocol
- Reduce intake of BCAA-rich foods like red meat, dairy, and whey protein supplements.
- Prioritize meeting protein needs with lower-BCAA sources, such as certain plant-based proteins.
- Animal studies often involve a ~50% reduction in BCAA intake, but no standard human protocol exists.
Flags
- Poses a significant risk of sarcopenia (age-related muscle loss) if total protein or essential amino acid needs are not met.
- Not recommended for individuals who are pregnant, frail, underweight, or have high protein requirements (e.g., athletes).
- May be difficult to implement and sustain due to the ubiquity of BCAAs in protein sources.
- Long-term effects and safety in humans are unknown.